Lupin, one of the leading pharmaceutical companies in India, announced today that the company has received final approval from the United States Food and Drug Administration (USFDA) for its Blisovi 24 Fe tablets (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate tablets, 75 mg).

Blisovi 24 Fe tablets are the are the AB rated generic version of Warner Chilcott's Loestrin 24 Fe tablets and are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Lupin's US subsidiary, Lupin Pharmaceuticals would commence promoting the product shortly in the US.

According to IMS MAT June 2015, Aricept had US sales of USD 56.8 million.

Shares of the company declined Rs 7.15, or 0.38%, to trade at Rs 1,892.15 at he BSE (11.29 a.m., Tuesday).